Patent details
91271
Product Name:
"natalizumab et ses dérivés pharmaceutiquement acceptables ( TYSABRI®)"
Basic Information
- Publication number:
- 91271
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP959087412
- Legal Status:
- Expired
- Application number:
- 91271
- First applicant's nationality:
- United States (US)
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 15/03/2017
- SPC Extension Agent Name:
-
Office FREYLINGER S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 16/11/2018
- SPC Extension Rejection Date:
-
Marketing Authorization
- Marketing Authorization Number:
- EU/1/06/346/001
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 27/06/2006
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 02/08/2006
- First Marketing Authorization date:
- 27/06/2006
- Grant date:
- 02/10/2006
- Activation date:
- 25/01/2015
- Publication date:
- 02/10/2006
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 25/01/2020
- SPC Extension Expiration:
- 25/07/2020
- Rejection date:
- Withdrawal date:
Owner
- From:
- 03/05/2017
-
-
- Name:
- Biogen MA, Inc.
- Address:
- 225 Binney Street, 02142, Cambridge, MA, United States (US)
History of Owners
- From:
- 06/11/2013
- To:
- 03/05/2017
- Name:
- BIOGEN IDEC MA INC.
- Address:
- CAMBRIDGE CENTER 14, CAMBRIDGE, MA 02142, United States (US)
- From:
- 06/11/2013
- To:
- 06/11/2013
- Name:
- BIOGEN IDEC INTERNATIONAL HOLDING LTD.
- Address:
- CANON'S COURT, 22 VICTORIA STREET, HAMILTON HM EX, Bermuda (BM)
- Name:
- ELAN PHARMACEUTICALS , INC.
- Address:
- 300 TECHNOLOGY SQUARE, THIRD FLOOR, CAMBRIDGE, MA 02139, United States (US)
- From:
- 02/08/2006
- To:
- 05/11/2013
- Name:
- ELAN PHARMACEUTICALS, INC.
- Address:
- GATEWAY BOULEVARD 800, SOUTH SAN FRANCISCO, CA 94080, United States (US)
Agent
1
- Name:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- From:
- 06/11/2013
- Address:
- PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
- To:
2
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 02/08/2006
- Address:
- ROUTE D'ARLON 234, PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
- 05/11/2013
Inventor
1
- Name:
- SALDANHA Jose
- Address:
- United Kingdom (GB)
2
- Name:
- JONES Tarran S.
- Address:
- United Kingdom (GB)
3
- Name:
- BENDIG Mary M.
- Address:
- United Kingdom (GB)
4
- Name:
- YEDNOCK Theodore A.
- Address:
- United States (US)
5
- Name:
- LEGER Olivier J.
- Address:
- United Kingdom (GB)
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2017/03
- Publication date:
- 21/07/2017
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2018/13
- Publication date:
- 13/12/2018
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
3
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2017/02
- Publication date:
- 22/06/2017
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20170000134A
- Date Registered:
- 03/05/2017
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- Biogen MA, Inc.
- Address:
- 225 Binney Street, 02142, Cambridge, MA, United States (US)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 30/01/2019
- Last Annual Fee Paid Number:
- 25
- Last Annual Fee Paid Amount:
- 450 Euro
- Payer:
- ENVOY INTERNATIONAL LIMITED